免疫治疗在胃癌的围手术期及转化治疗中的应用和挑战
Application and challenge of immunotherapy in perioperative therapy of gastric cancer
薛驰 1高鹏 1朱志 1王振宁1
作者信息
- 1. 中国医科大学附属第一医院胃肠肿瘤外科,辽宁 沈阳 110001
- 折叠
摘要
胃癌是中国常见的消化系统恶性肿瘤之一,进展期及晚期患者占比高,围手术期治疗方案的选择始终是临床上的难点.对多数局部进展期胃癌,围手术期治疗模式相较于标准根治术联合术后辅助化疗的模式,也许可以进一步改善患者生存,但传统化疗方案的疗效已达到平台期,传统分子靶向治疗进展相对缓慢,近年来,随着免疫治疗在晚期胃癌治疗中的地位不断提升,越来越多的临床研究表明,免疫治疗在围手术期胃癌患者中也可以取得较好的疗效.本文就近年来免疫治疗在胃癌围手术期中应用的研究进展进行述评.
Abstract
Gastric cancer is one of the common malignant tumors of digestive system in our country.The proportion of patients in advanced and late stage is large,and the choice of perioperative treatment program is always difficult in clinic.For most locally advanced gastric cancer,compared with standard radical surgery combined with postoperative adjuvant chemotherapy,perioperative treatment mode may further improve the survival of patients.However,the efficacy of conventional chemotherapy regimen has reached a plateau,while the progress of traditional molecular targeted therapy is relatively slow.In recent years,with the increasing role of immunotherapy in the treatment of advanced gastric cancer,more and more clinical studies have shown that immunotherapy can also achieve better efficacy in perioperative gastric cancer patients.This article reviewed the research progress of immunotherapy in perioperative gastric cancer in recent years.
关键词
胃癌/免疫治疗/临床试验/新辅助治疗/转化治疗Key words
Gastric cancer/Immunotherapy/Clinical trials/Neoadjuvant therapy/Conversion therapy引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
万方数据